Quality Of Life clinical trials

Explore recruiting quality of life clinical trials.

Recruiting quality of life studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Quality Of Life trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of H2 inhalation therapy on early recurrence after atrial fibrillation ablation. Multicenter, open-label, randomized phase II controlled trial.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A national randomized placebo-controlled double-blind multicenter trial of LT4/LT3 combination therapy in patients with autoimmune hypothyroidism: the T3-4-Hypo trial

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

PDH-RAVICTI - A PHASE II, MULTICENTRIC, PROSPECTIVE, NON-COMPARATIVE CLINICAL TRIAL TO ASSESS THE EFFICACY AND SAFETY OF THE TREATMENT OF PYRUVATE DEHYDROGENASE DEFICIENCY (PDH) PATIENTS WITH GLYCEROL PHENYLBUTYRATE (RAVICTI®)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Improvement of Quality of Life by Cannabinoids in Oncologic Patients (BELCANTO)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label, single-center, exploratory study of the safety and efficacy of avalglucosidase alfa in patients with non-classic Pompe disease aged ≥ 5 years.

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

The CLEAN-DUCT / TRITICC-3 trial - Phase IIa, prospective, single arm, open label, non-randomized, multi-center pilot study of durvalumab (MEDI4736) + intraductal radiofrequency ablation (ID-RFA) in extrahepatic cholangiocarcinoma

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Quality Of Life trials by city

Quality Of Life in Toronto Quality Of Life in Vancouver Quality Of Life in Montreal Quality Of Life in Calgary Quality Of Life in Edmonton Quality Of Life in Ottawa Quality Of Life in Winnipeg Quality Of Life in Quebec City Quality Of Life in Hamilton Quality Of Life in Kitchener Quality Of Life in London Quality Of Life in Halifax Quality Of Life in New York Quality Of Life in Los Angeles Quality Of Life in Chicago Quality Of Life in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease